| 000 | 01242 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250517172638.0 | ||
| 264 | 0 | _c20180726 | |
| 008 | 201807s 0 0 eng d | ||
| 022 | _a1740-634X | ||
| 024 | 7 |
_a10.1038/npp.2017.209 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBoggs, Douglas L | |
| 245 | 0 | 0 |
_aClinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ _h[electronic resource] |
| 260 |
_bNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology _cJan 2018 |
||
| 300 |
_a142-154 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCannabidiol _xadverse effects |
| 650 | 0 | 4 |
_aCannabinoid Receptor Agonists _xadverse effects |
| 650 | 0 | 4 |
_aDronabinol _xadverse effects |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aHumans |
| 700 | 1 | _aNguyen, Jacques D | |
| 700 | 1 | _aMorgenson, Daralyn | |
| 700 | 1 | _aTaffe, Michael A | |
| 700 | 1 | _aRanganathan, Mohini | |
| 773 | 0 |
_tNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology _gvol. 43 _gno. 1 _gp. 142-154 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/npp.2017.209 _zAvailable from publisher's website |
| 999 |
_c27531988 _d27531988 |
||